Cargando…
The Effect of Semaglutide on Blood Pressure in Patients without Diabetes: A Systematic Review and Meta-Analysis
(1) Background: Recent advances in the pharmacological treatment of obesity with glucagon-like peptide-1 receptor agonists (GLP-1 RA) highlight the potential to target excess body weight to improve blood pressure (BP). This review aimed to determine the BP reduction in trials of semaglutide for weig...
Autores principales: | Kennedy, Cormac, Hayes, Peter, Salama, Sulafa, Hennessy, Martina, Fogacci, Federica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917722/ https://www.ncbi.nlm.nih.gov/pubmed/36769420 http://dx.doi.org/10.3390/jcm12030772 |
Ejemplares similares
-
Effect of semaglutide and liraglutide in individuals with obesity or
overweight without diabetes: a systematic review
por: Deng, You, et al.
Publicado: (2022) -
Weekly Semaglutide vs. Liraglutide Efficacy Profile: A Network Meta-Analysis
por: Alsugair, Hassan A., et al.
Publicado: (2021) -
Blood Pressure Increase following COVID-19 Vaccination: A Systematic Overview and Meta-Analysis
por: Angeli, Fabio, et al.
Publicado: (2022) -
Efficacy and Safety of Semaglutide for Weight Loss in Obesity Without Diabetes: A Systematic Review and Meta-Analysis
por: Tan, Hanna Clementine, et al.
Publicado: (2022) -
Maternal overnutrition elevates offspring’s blood pressure—A systematic review and meta‐analysis
por: Eitmann, Szimonetta, et al.
Publicado: (2022)